Nintedanib

Details

Files

Generic Name:

Nintedanib

Project Status:

Complete

Therapeutic Area:

Idiopathic pulmonary fibrosis

Manufacturer:

Boehringer Ingelheim (Canada) Ltd.

Call for patient/clinician input open:

March 13, 2015

Brand Name:

Ofev

Project Line:

Reimbursement Review

Project Number:

SR0426-000

Call for patient/clinician input closed:

May 4, 2015

NOC Status at Filing:

Pre NOC

Submission Type:

Initial

Indications:

Idiopathic pulmonary fibrosis (IPF)

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

October 15, 2015

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Patient Group Input Submissions View PDF

Last Updated : March 13, 2015